Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress. [electronic resource]
- Archives of medical research Nov 2012
- 694-8 p. digital
Publication Type: Journal Article; Review
1873-5487
10.1016/j.arcmed.2012.09.009 doi
Alzheimer Disease--drug therapy Amyloidosis--metabolism Antibodies, Monoclonal, Humanized--adverse effects Energy Metabolism Humans Mitochondria--metabolism Models, Neurological Oxidative Stress Phosphorylation Systems Biology--trends Treatment Failure tau Proteins--metabolism